The Quebec pregnancy cohort - Prevalence of medication use during gestation and pregnancy outcomes

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Beŕard, Anick ^a,b   Sheehy, Odile ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTION; ADULT; ARTICLE; CANADA; COHORT ANALYSIS; DELIVERY; DRUG USE; FEMALE; GESTATIONAL AGE; HEALTH INSURANCE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PERINATAL PERIOD; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PREVALENCE; PUERPERAL DEPRESSION; PUERPERIUM; QUEBEC PREGNANCY TOOL; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; EPIDEMIOLOGY; EVALUATION STUDY; FACTUAL DATABASE; PERINATAL CARE; PHARMACOEPIDEMIOLOGY; PREGNANCY; PROCEDURES;

DRUG;

COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; PERINATAL CARE; PHARMACEUTICAL PREPARATIONS; PHARMACOEPIDEMIOLOGY; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; QUEBEC; QUESTIONNAIRES;

EID: 84899434204     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093870     Document Type: Article

References (51)

1. Lenz W (1988) A short history of thalidomide embryopathy. Teratology 38: 203-215.
2. Koren G, Pastuszak A, Ito S (1998) Drugs in pregnancy. N Engl J Med 338: 1128-1137. (Pubitemid 28227484)
3. Olesen C, Steffensen FH, Nielsen GL, de Jong-van den Berg L, Olsen J, et al. (1999) Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Eur J Clin Pharmacol 55: 139-144. (Pubitemid 29196267)
4. Cassina M, Johnson DL, Robinson LK, Braddock SR, Xu R, et al. (2012) Pregnancy outcome in women exposed to leflunomide before or during pregnancy. Arthritis Rheum 64: 2085-2094.
5. Einarson A, Choi J, Koren G, Einarson T (2011) Outcomes of infants exposed to multiple antidepressants during pregnancy: results of a cohort study. J Popul Ther Clin Pharmacol 18: e390-396.
6. Chambers CD, Johnson DL, Robinson LK, Braddock SR, Xu R, et al. (2010) Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum 62: 1494-1503.
7. Nulman I, Koren G, Rovet J, Barrera M, Pulver A, et al. (2012) Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry 169: 1165-1174.
8. Nulman I, Rovet J, Greenbaum R, Loebstein M, Wolpin J, et al. (2001) Neurodevelopment of adopted children exposed in utero to cocaine: the Toronto Adoption Study. Clin Invest Med 24: 129-137. (Pubitemid 32681617)
9. Nakhai-Pour HR, Broy P, Berard A (2010) Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ 182: 1031-1037.
10. Ramos E, St-Andre M, Rey E, Oraichi D, Berard A (2008) Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 192: 344-350. (Pubitemid 351692378)
11. Kornum JB, Nielsen RB, Pedersen L, Mortensen PB, Norgaard M (2010) Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin Epidemiol 2: 29-36.
12. Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, et al. (2012) Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 32: 186-194.
13. Reis M, Kallen B (2010) Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 40: 1723-1733.
14. Berard A, Ramos E, Rey E, Blais L, St-Andre M, et al. (2007) First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 80: 18-27.
15. Berard A, Lacasse A (2009) Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database. Can J Clin Pharmacol 16: e360-369.
16. WHO Health Organization (1978) International Statistical Classification of Diseases and Related Health Problems (ICD-9). 9th revision. Geneva.
17. WHO Health Organization (2010) International Statistical Classification of Diseases and Related Health Problems (ICD-10). 10th revision. Geneva.
18. Tamblyn R, Lavoie G, Petrella L, Monette J (1995) The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 48: 999-1009.
19. Levy AR, Mayo NE, Grimard G (1995) Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981-1992. Am J Epidemiol 142: 428-436.
20. Vilain A, Otis S, Forget A, Blais L (2008) Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women. Pharmacoepidemiol Drug Saf 17: 345-353. (Pubitemid 351566350)
21. Kulaga S, Berard A (2010) Congenital malformations: agreement between diagnostic codes in an administrative database and mothers' reports. J Obstet Gynaecol Can 32: 549-554.
22. Blais L, Berard A, Kettani FZ, Forget A (2013) Validity of congenital malformation diagnostic codes recorded in Quebec's administrative databases. Pharmacoepidemiol Drug Saf 22: 881-889.
23. Rûgie de l'assurance maladie du Quûbec (2013) List of Medications. pp. Available: http://www.ramq.gouv.qc.ca/en/publications/citizens/ legal-publications/Pages/list- medications.aspx. Accessed 2013 Oct 3.
24. Moussally K, Berard A (2010) Exposure to herbal products during pregnancy and the risk of preterm birth. Eur J Obstet Gynecol Reprod Biol 150: 107-108.
25. Health Canada (2002) Congenital anomalies in Canada - A Perinatal Health Report: Minister of Health.
26. Beyens MN, Guy C, Ratrema M, Ollagnier M (2003) Prescription of drugs to pregnant women in France: the HIMAGE study. Therapie 58: 505-511. (Pubitemid 38327271)
27. Egen-Lappe V, Hasford J (2004) Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 60: 659-666. (Pubitemid 40064599)
28. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL (2000) Prescription of drugs during pregnancy in France. Lancet 356: 1735-1736.
29. Institut de la Statistique du Québec (2013) Interruptions volontaires de grossesse (nombre, rapport pour 100 naissances et taux pour 1 000 femmes), hystérectomies, ligatures, vasectomies, réanastomoses et vasovasostomies. Quebec, 1971-2011. Available: http://www.stat.gouv.qc.ca/ statistiques/population-demographie/naissance-fecondite/415.htm. Accessed 2013 Nov 15.
30. Jones RK, Zolna MR, Henshaw SK, Finer LB (2008) Abortion in the United States: incidence and access to services, 2005. Perspect Sex Reprod Health 40: 6-16.
31. de la Rochebrochard E, Thonneau P (2002) Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study. Hum Reprod 17: 1649-1656.
32. Nybo AA, Wohlfahrt J, Christens P, Olsen J, Melbye M (2000) Is maternal age an independent risk factor for fetal loss? West J Med 173: 331.
33. Institut de la Statistique du Québec (2011) Naissances selon la durée de la grossesse et le poids à la naissance, par région administrative, Québec, 2011. Available: http://www.stat.gouv.qc.ca/statistiques/population-demographie/ naissance-fecondite/419.htm Accessed 15 November 2013.
34. Public Health Canada (2008) Ottawa MoH. Canadian Perinatal Health Report.
35. Keirse MJ, Hanssens M, Devlieger H (2009) Trends in preterm births in Flanders, Belgium, from 1991 to 2002. Paediatr Perinat Epidemiol 23: 522-532.
36. Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371: 75-84.
37. Botting BJ, Davies IM, Macfarlane AJ (1987) Recent trends in the incidence of multiple births and associated mortality. Arch Dis Child 62: 941-950. (Pubitemid 18090893)
38. Institut de la Statistique du Québec (2013) Naissances selon le type (simple ou multiple). Québec, 1988-2012. Available: http://www.stat.gouv.qc.ca/statistiques/population- demographie/naissance- fecondite/450-type.htm. Accessed 2013 Nov 19
39. Beckman DA, Brent RL (1984) Mechanisms of teratogenesis. Annu Rev Pharmacol Toxicol 24: 483-500. (Pubitemid 14129544)
40. Laberge AM, Michaud J, Richter A, Lemyre E, Lambert M, et al. (2005) Population history and its impact on medical genetics in Quebec. Clin Genet 68: 287-301. (Pubitemid 41341606)
41. SantÛ Canada (2008) Maladies chroniques au Canada. Canada: Ministre des Travaux publics et Services gouvernementaux Canada. Vol 23, No 3.
42. Institut de la Statistique du Québec (2011) Tendances temporelles de la prévalence etde l'incidence du diabète, et mortalité chez les diabétiques au Québec, de 2000-2001 à 2006-2007.
43. SOGC guideline (2008) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.
44. Health Canada (2002) Enquête sur la santé dans les collectivités canadiennes (ESCC), volet Santé mentale et bien-être,cycle 1.2. Québec.
45. Reck C, Stehle E, Reinig K, Mundt C (2009) Maternity blues as a predictor of DSM-IV depression and anxiety disorders in the first three months postpartum. J Affect Disord 113: 77-87.
46. Wenzel A, Haugen EN, Jackson LC, Brendle JR (2005) Anxiety symptoms and disorders at eight weeks postpartum. J Anxiety Disord 19: 295-311. (Pubitemid 40431043)
47. Health Canada (2007) Vitamin D supplementation: Recommendations for Canadian mothers and infants. Paediatr Child Health 12: 583-598.
48. Cote SM, Borge AI, Geoffroy MC, Rutter M, Tremblay RE (2008) Nonmaternal care in infancy and emotional/behavioral difficulties at 4 years old: moderation by family risk characteristics. Dev Psychol 44: 155-168.
49. Jobin-Gervais K, Sheehy O, Berard A (2013) Can we Rely on Pharmacy Claims Databases to Ascertain Maternal Use of Medications during Pregnancy? Pharmacoepidemiology and Drug Safety 22: 155.
50. Berard A, Nakhai-Pour H, Kulaga S (2009) Impact of missing data on potential confounders in perinatal pharmacoepidemiology studies using administrative databases. Canadian Association for Population Therapeutics (CAPT). Montreal, Quebec, Canada: Can J Clin Pharmacol. pp. e207.
51. Ofori B, Rey E, Berard A (2007) Risk of congenital anomalies in pregnant users of statin drugs. Br J Clin Pharmacol 64: 496-509. (Pubitemid 47404298)